Structure and function of ETAA16: A novel cell surface antigen in Ewing's tumours

Cancer Immunology, Immunotherapy

Volumn 55, Issue 4, 2006, Pages 363-374

  Borowski, A ^a,b   Dirksen, U ^b,d   Lixin, L ^b   Shi, R L ^b   Gobel U ^b   Schneider, E M ^c  

^a UNIVERSITY OF BONN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

ETAA16; Ewing's family of tumour; Tumour associated antigen

Indexed keywords

MEMBRANE ANTIGEN; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN ETAA16; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BRAIN; CONTROLLED STUDY; DISEASE ASSOCIATION; EWING SARCOMA; FLOW CYTOMETRY; GAP JUNCTION; GENE SEQUENCE; HUMAN; HUMAN CELL; KIDNEY; LIVER; MATHEMATICAL COMPUTING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BONE NEOPLASMS; CATTLE; GENE LIBRARY; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, EWING'S; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 30444460757     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-005-0017-6     Document Type: Article

References (37)

1. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M (1991) MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67:1886
2. Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV, Denny CT (1998) EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17:2039
3. Arvand A, Denny CT (2001) Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20:5747
4. Borowski A, van Valen F, et al. (1999) Monomorphic HLA class I-(non-A, non-B) expression on Ewing's tumor cell lines, modulation by TNF-α and IFN-γ. Immunobiology 200:1
5. Braun BS, Frieden R, Lessnick SL, May WA, Denny CT (1995) Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis. Mol Cell Biol 15:4623
6. Cavazzana AO, Miser JS, Jefferson J, Triche TJ (1987) Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol 127:507
7. Chomzynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156
8. Dixkens C, Posseckert G, Keller T, Hameister H (1998) Structural analysis of the amplified IFN-beta and DHFR genes in a Chinese hamster ovary cell line using multicolour FISH analysis. Chromosome Res 6:329
9. Franchi A, Pasquinelli G, et al. (2001) Immunohistochemical and ultrastructural investigation of neural differentiation in Ewing sarcoma/PNET of bone and soft tissues. Ultrastruct Pathol 25:219
10. Granowetter L (1995) Ewing's sarcoma and extracranial peripheral neuroectodermal tumors. Curr Opin Oncol 7:355
11. Hahm KB, Cho K, et al. (1999) Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23:222
12. Jankowski J, Holst MI, Liebig C, Oberdick J, Baader SL (2004) Engrailed-2 negatively regulates the onset of perinatal Purkinje cell differentiation. J Comp Neurol 472:87
13. Jürgens HF (1994) Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Curr Opin Oncol 6:391
14. Kato K, Arai K, et al. (2000) Epithelioid leiomyosarcoma in a non-immunocompromised infant: additional differential diagnosis of pediatric "Round Cell Tumors". Mod Pathol 13:1156
15. Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283
16. Kozak M (1996) Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 7:563
17. Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105
18. Lander ES, Linton LM et al. (2001) Initial sequencing and analysis of the human genome. Nature 409:860
19. Laws HJ, Burdach S, et al. (1999) Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. a single-center report. Strahlenther Onkol 175:488
20. May WA, Arvand A, Thompson AD, Braun BS, Wright M, Denny CT (1997) EW S/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet 17:495
21. Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R (2000) Strategies for immunotherapy of cancer. Adv Immunol 75:235
22. Pagani A, Fischer-Colbrie R, Eder U, Pellin A, Llombart-Bosch A, Bussolati G (1995) Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence. Int J Cancer 63:738
23. Paulussen M, Ahrens S, et al. (2001) Localized Ewing tumor of bone:final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19:1818
24. Remy P, Baltzinger M (2000) The Ets-transcription factor family in embryonic development: lessons from the amphibian and bird. Oncogene 19:6417
25. Ribas A, Butterfield LH, Glaspy JA, Economou JS (2003) Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol 21:2415
26. Sambrook J, Maniatis T, Fritsch EF (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbour Laboratory Press, New York
27. Schaefer KL, Wai DH, et al. (2002) Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays. Virchows Arch 440:476
28. Shi LR, Eichelbauer D, Borchard F, Jurgens H, Gobel U, Schneider EM (1994) Specificity and function of monoclonal antibodies directed against Ewing sarcoma cells. Cancer Immunol Immunother 38:208
29. Slaper-Cortenbach IC, Admiraal LG, Kerr JM, van Leeuwen EF, von dem Borne AE, Tetteroo PA (1988) Flow-cytometric detection of terminal deoxynucleotidyl transferase and other intracellular antigens in combination with membrane antigens in acute lymphatic leukemias. Blood 72:1639
30. Spieker N, van Sluis P, et al. (2001) The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics 71:214
31. Staege MS, Hutter C, et al. (2004) DNA Microarrays reveal relationship of ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64:8213
32. Stratakis CA, Taymans SE (1998) Structure of the gene coding for calcineurin B (PPP3R1) and mapping to D2S358-D2S1778 (chromosomal region 2p15). DNA Seq 9:227
33. Urban JL, Schreiber H (1992) Tumor Antigens. Annu Rev Immunol 10:617
34. van Valen F (1999) Ewing's sarcoma family of tumors. In: Masters JRW, Palsson B (eds), Human cell culture, vol. 1. Kluwer, Dordrecht pp 55-85
35. Vlaeminck-Guillem V, Carrere S, Dewitte F, Stehelin D, Desbiens X, Duterque-Coquillaud M (2000) The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis. Mech Dev 91:331
36. Watanabe G, Nishimori H, et al. (2003) Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Genes Chromosomes Cancer 36:224
37. Zwerner JP, May WA (2001) PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene 20:626